Evidence map›Paper›PMID 28946857›Full record

ArticleBMC medical research methodology2017

Predicting the multi-domain progression of Parkinson's disease: a Bayesian multivariate generalized linear mixed-effect model.

Ming Wang, Zheng Li, Eun Young Lee, Mechelle M Lewis, Lijun Zhang, Nicholas W Sterling, Daymond Wagner, Paul Eslinger, Guangwei Du, Xuemei Huang

Abstract read
In one paragraph

Article in BMC medical research methodology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ming WangDepartments of Public Health Sciences, Pennsylvania State University Hershey Medical Center, Hershey, PA, 17033, USA. mwang@phs.psu.edu.
Zheng LiDepartments of Public Health Sciences, Pennsylvania State University Hershey Medical Center, Hershey, PA, 17033, USA.
Eun Young LeeDepartment of Neurology, Pennsylvania State University Hershey Medical Center, Hershey, PA, 17033, USA.
Mechelle M LewisDepartment of Neurology, Pennsylvania State University Hershey Medical Center, Hershey, PA, 17033, USA.
Lijun ZhangDepartment of Biochemistry and Molecular Biology, Pennsylvania State University Hershey Medical Center, Hershey, PA, 17033, USA.
Nicholas W SterlingDepartment of Neurology, Pennsylvania State University Hershey Medical Center, Hershey, PA, 17033, USA.
Daymond WagnerDepartment of Neurology, Pennsylvania State University Hershey Medical Center, Hershey, PA, 17033, USA.
Paul EslingerDepartments of Public Health Sciences, Pennsylvania State University Hershey Medical Center, Hershey, PA, 17033, USA.
Guangwei DuDepartment of Neurology, Pennsylvania State University Hershey Medical Center, Hershey, PA, 17033, USA.
Xuemei HuangDepartment of Neurology, Pennsylvania State University Hershey Medical Center, Hershey, PA, 17033, USA. xuemei@psu.edu.

Funding

Penn State Clinical and Translational Science InstituteUL1TR002014 · NCATS · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI KRASCHNEWSKI, JENNIFER L. · 2016 to 2025
$33.7M
Penn State Clinical and Translational Science InstituteUL1TR000127 · NCATS · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI SINOWAY, LAWRENCE I · 2012 to 2015
$17.1M
Penn State Institutional Career Development CoreKL2TR002015 · NCATS · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI VAN SCOY, LAUREN JODI · 2016 to 2025
$7.8M
Multimodal MRI Markers of Nigrostriatal Pathology in Parkinson's DiseaseU01NS082151 · NINDS · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI HUANG, XUEMEI · 2012 to 2016
$4.2M
NRSA Training CoreTL1TR002016 · NCATS · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI THOMAS, GAIL D. · 2016 to 2025
$3.4M
Penn State Clinical and Translational Science InstituteKL2TR000126 · NCATS · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI SINOWAY, LAWRENCE I · 2012 to 2015
$3.2M
Structural MRI marker(s) of Parkinson's Disease's ProgressionR01NS060722 · NINDS · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI HUANG, XUEMEI · 2009 to 2013
$2.9M
NCATS NIH HHS KL2 TR000126NCATS NIH HHS KL2 TR002015NCATS NIH HHS TL1 TR002016NCATS NIH HHS UL1 TR000127NCATS NIH HHS UL1 TR002014NINDS NIH HHS R01 NS060722NINDS NIH HHS U01 NS082151
6 · The paper itself

Abstract

backgroundIt is challenging for current statistical models to predict clinical progression of Parkinson's disease (PD) because of the involvement of multi-domains and longitudinal data.

methodsPast univariate longitudinal or multivariate analyses from cross-sectional trials have limited power to predict individual outcomes or a single moment. The multivariate generalized linear mixed-effect model (GLMM) under the Bayesian framework was proposed to study multi-domain longitudinal outcomes obtained at baseline, 18-, and 36-month. The outcomes included motor, non-motor, and postural instability scores from the MDS-UPDRS, and demographic and standardized clinical data were utilized as covariates. The dynamic prediction was performed for both internal and external subjects using the samples from the posterior distributions of the parameter estimates and random effects, and also the predictive accuracy was evaluated based on the root of mean square error (RMSE), absolute bias (AB) and the area under the receiver operating characteristic (ROC) curve.

resultsFirst, our prediction model identified clinical data that were differentially associated with motor, non-motor, and postural stability scores. Second, the predictive accuracy of our model for the training data was assessed, and improved prediction was gained in particularly for non-motor (RMSE and AB: 2.89 and 2.20) compared to univariate analysis (RMSE and AB: 3.04 and 2.35). Third, the individual-level predictions of longitudinal trajectories for the testing data were performed, with ~80% observed values falling within the 95% credible intervals.

conclusionsMultivariate general mixed models hold promise to predict clinical progression of individual outcomes in PD.

trial registrationThe data was obtained from Dr. Xuemei Huang's NIH grant R01 NS060722 , part of NINDS PD Biomarker Program (PDBP). All data was entered within 24 h of collection to the Data Management Repository (DMR), which is publically available ( https://pdbp.ninds.nih.gov/data-management ).

Indexed as

AlgorithmsBayes TheoremLinear ModelsAgedDisease ProgressionFemaleHumansLongitudinal StudiesMaleMiddle AgedMultivariate AnalysisParkinson DiseasePrognosisTime FactorsDynamic predictionGeneralized linear mixed-effect modelImbalanceMotor symptomsMultivariate longitudinal dataNon-motor symptomsParkinson’s disease

Identifiers

PMID28946857
PMCPMC5613469

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.